BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771102. A total of 20 filers reported holding BELLEROPHON THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,567,000 | +16.3% | 647,671 | 0.0% | 0.00% | – |
| Q1 2018 | $1,347,000 | -35.4% | 647,671 | -19.8% | 0.00% | – |
| Q4 2017 | $2,084,000 | +37.6% | 807,770 | -24.3% | 0.00% | – |
| Q3 2017 | $1,515,000 | +2.0% | 1,066,970 | -3.7% | 0.00% | – |
| Q2 2017 | $1,485,000 | -12.8% | 1,108,470 | -3.0% | 0.00% | – |
| Q1 2017 | $1,703,000 | +169.0% | 1,142,970 | -5.4% | 0.00% | – |
| Q4 2016 | $633,000 | -62.6% | 1,208,070 | 0.0% | 0.00% | – |
| Q3 2016 | $1,691,000 | -19.1% | 1,208,070 | 0.0% | 0.00% | – |
| Q2 2016 | $2,090,000 | -33.0% | 1,208,070 | -4.7% | 0.00% | – |
| Q1 2016 | $3,119,000 | -19.1% | 1,267,981 | -2.6% | 0.00% | -100.0% |
| Q4 2015 | $3,854,000 | -43.0% | 1,302,070 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $6,758,000 | -34.5% | 1,302,070 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $10,325,000 | -13.6% | 1,302,070 | 0.0% | 0.00% | -50.0% |
| Q1 2015 | $11,953,000 | – | 1,302,070 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Puissance Capital Management LP | 8,298,755 | $17,261,000 | 14.88% |
| NEW MOUNTAIN VANTAGE ADVISERS, L.L.C. | 15,138,486 | $31,488,000 | 2.58% |
| VHCP Management II, LLC | 4,149,378 | $8,631,000 | 2.08% |
| Boxer Capital, LLC | 1,857,143 | $3,863,000 | 0.41% |
| Telemetry Investments, L.L.C. | 199,000 | $414,000 | 0.16% |
| EAM Investors, LLC | 232,290 | $483,000 | 0.08% |
| DRW Securities, LLC | 70,000 | $146,000 | 0.01% |
| Renaissance Technologies | 1,032,900 | $2,148,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 23,000 | $48,000 | 0.00% |
| STATE STREET CORP | 13,800 | $29,000 | 0.00% |